ContextVision AB (publ) (OSL: CONTX)
Norway
· Delayed Price · Currency is NOK
5.10
+0.32 (6.69%)
Nov 21, 2024, 4:15 PM CET
ContextVision AB Revenue
ContextVision AB had revenue of 31.30M SEK in the quarter ending September 30, 2024, a decrease of -6.63%. This brings the company's revenue in the last twelve months to 135.45M, up 0.02% year-over-year. In the year 2023, ContextVision AB had annual revenue of 132.60M with 7.62% growth.
Revenue (ttm)
135.45M SEK
Revenue Growth
+0.02%
P/S Ratio
2.63
Revenue / Employee
3.39M SEK
Employees
40
Market Cap
369.82M NOK
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 132.60M | 9.39M | 7.62% |
Dec 31, 2022 | 123.21M | 23.69M | 23.81% |
Dec 31, 2021 | 99.52M | 4.77M | 5.04% |
Dec 31, 2020 | 94.75M | -566.00K | -0.59% |
Dec 31, 2019 | 95.31M | 4.41M | 4.85% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nordhealth AS | 513.12M |
Medistim ASA | 541.82M |
Carasent ASA | 264.80M |
Photocure ASA | 526.25M |
Nykode Therapeutics AS | 69.44M |
ArcticZymes Technologies ASA | 110.76M |
Gentian Diagnostics ASA | 154.12M |
Hofseth BioCare ASA | 248.08M |